Drug stocks, fortified by hopes of bigger US sales, lifted European shares on Friday to end the week flat, though still near their best levels of the year.
The FTSE Eurotop 300 index ended the day up 0.5 percent at 939.91 points, with more than two shares rising for each one falling.
The benchmark struggled to match this year's peak set last week as Wall Street trading was mixed, but is up 10.5 percent for the year after its hefty rally from a six-year nadir in March.
"The market is no longer as good value as it was. Although we have a lot of headwind behind it with economic data coming up nicely, we have had several months in a row of good performance and I would not be surprised to see a pause," said Richard Champion of Pavilion Asset Management.
Among the standouts, ING Groep fell 1.4 percent to 18.6 euros as the Dutch firm, Europe's number three insurer, offered cautious guidance after reporting a weaker than expected third-quarter net operating profit.
Italian bank Capitalia reported forecast-beating quarterly numbers, sending its shares higher.
Parmalat ended the week down 12 percent on concerns about the Italian food group's balance sheet, sinking further on Friday on news its finance director had resigned.
Autos lagged as new car sales in western Europe slipped last month, and a dip in US retail sales last month was blamed on weaker demand. Europe's biggest carmaker Volkswagen said it would cut investment over the next five years, and its stock eased a touch to 44.9 euros.
The DJ Euro Stoxx 50 index, a benchmark of euro zone blue chips, closed up 0.8 percent at 2,656.9 points, while the FTSE 100 in London clocked up its best close since late August last year after hitting fresh yearly highs.
The construction sector benefited from signs of a European and Japanese economic recovery, hitting new highs for the year.
Glass maker Saint-Gobain rose three percent, while cement makers Lafarge, Holcim and Heidelbergercement all rose two percent or more.
"We are having a bit more rotation into what has underperformed, like some of the cyclicals. People are scouting around for what has not been involved in the rally," Champion said.
The DJ Stoxx health index hit yearly high on hopes reform of the US Medicare program for seniors would boost demand for prescription medicines in the world's biggest market.
"Investors are getting more confident that there will be a Medicare drug benefit passed in the near term," said Marc Booty, pharmaceuticals analyst at Commerzbank.
Pavilion Asset Management's Champion said it was too early to call a turn in the healthcare sector.
French drug firm Aventis SA rose 5.8 percent, while Britain's GlaxoSmithKline Plc tacked on 2.4 percent. Swiss Novartis AG rallied 3.7 percent, while Anglo-Swedish AstraZeneca gained 2.8 percent.
The Eurotop 300 index is only some six points from its yearly high set a week ago, underpinned by third-quarter earnings, the best since the start of 2000, and further signs of recovery.
Eurostat data on Friday confirmed the euro zone economy grew at 0.4 percent in the third quarter, its fastest rate in a year, and should pick up even more steam in the next six months.
Data on Friday showed a strong improvement in the University of Michigan index of US consumer confidence, and a surprise rise in producer prices.
After investors pushed stocks to new highs, there remained nagging doubts about the rally's sustainability, said Anais Faraj, strategist at Nomura.
"We remain positive, though acknowledge the rough terrain," Faraj added.
JP Morgan investment bank said global growth was supporting European equities and, at this point in the economic cycle, equities usually outperform bonds as earnings grow while bond yields see little lift, thus reducing pressure on a stock's valuation multiple.
In New York, as bourses shut the Dow Jones Industrial Average was flat at 9,846 points, while the NASDAQ Composite had shed 0.6 percent to 1,956 points.
EXTRATERRITORIAL REACH: China extended its legal jurisdiction to ban some dual-use goods of Chinese origin from being sold to the US, even by third countries Beijing has set out to extend its domestic laws across international borders with a ban on selling some goods to the US that applies to companies both inside and outside China. The new export control rules are China’s first attempt to replicate the extraterritorial reach of US and European sanctions by covering Chinese products or goods with Chinese parts in them. In an announcement this week, China declared it is banning the sale of dual-use items to the US military and also the export to the US of materials such as gallium and germanium. Companies and people overseas would be subject to
WORLD DOMINATION: TSMC’s lead over second-placed Samsung has grown as the latter faces increased Chinese competition and the end of clients’ product life cycles Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) retained the No. 1 title in the global pure-play wafer foundry business in the third quarter of this year, seeing its market share growing to 64.9 percent to leave South Korea’s Samsung Electronics Co, the No. 2 supplier, further behind, Taipei-based TrendForce Corp (集邦科技) said in a report. TSMC posted US$23.53 billion in sales in the July-September period, up 13.0 percent from a quarter earlier, which boosted its market share to 64.9 percent, up from 62.3 percent in the second quarter, the report issued on Monday last week showed. TSMC benefited from the debut of flagship
TENSE TIMES: Formosa Plastics sees uncertainty surrounding the incoming Trump administration in the US, geopolitical tensions and China’s faltering economy Formosa Plastics Group (台塑集團), Taiwan’s largest industrial conglomerate, yesterday posted overall revenue of NT$118.61 billion (US$3.66 billion) for last month, marking a 7.2 percent rise from October, but a 2.5 percent fall from one year earlier. The group has mixed views about its business outlook for the current quarter and beyond, as uncertainty builds over the US power transition and geopolitical tensions. Formosa Plastics Corp (台灣塑膠), a vertically integrated supplier of plastic resins and petrochemicals, reported a monthly uptick of 15.3 percent in its revenue to NT$18.15 billion, as Typhoon Kong-rey postponed partial shipments slated for October and last month, it said. The
COLLABORATION: The operations center shows the close partnership between Taiwan and Japan in the field of semiconductors, Minister of Economic Affairs J.W. Kuo said Tokyo Electron Ltd, Asia’s biggest semiconductor equipment supplier, yesterday launched a NT$2 billion (US$61.5 million) operations center in Tainan as it aims to expand capacity and meet growing demand. Its new Taiwan Operations Center is expected to help customers release their products faster, boost production efficiency and shorten equipment repair time in a cost-effective way, the company said. The center is about a five-minute drive from the factories of its major customers such as Taiwan Semiconductor Manufacturing Co’s (TSMC, 台積電) advanced 3-nanometer and 2-nanometer fabs. The operations center would have about 1,000 employees when it is fully utilized, the company
RSS